Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 21, 2014; 20(27): 8921-8927
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8921
Which strategy after first-line therapy in advanced colorectal cancer?
Coinu Andrea, Petrelli Fausto, Borgonovo Karen Francesca, Cabiddu Mary, Ghilardi Mara, Lonati Veronica, Barni Sandro
Coinu Andrea, Petrelli Fausto, Borgonovo Karen Francesca, Cabiddu Mary, Ghilardi Mara, Lonati Veronica, Barni Sandro, Medical Oncology Unit, Oncology Department, Azienda Ospedaliera di Treviglio, Treviglio, 24047 BG, Italy
Author contributions: All authors contributed equally to the acquisition of data, drafting of the article and final approval of the version to be published.
Correspondence to: Coinu Andrea, MD, Medical Oncology Unit, Oncology Department, Azienda Ospedaliera di Treviglio, Piazzale Ospedale 1, Treviglio, 24047 BG, Italy. artefice2003@hotmail.com
Telephone: +39-363-424303 Fax: +39-363-424380
Received: September 29, 2013
Revised: December 31, 2013
Accepted: April 1, 2014
Published online: July 21, 2014
Processing time: 294 Days and 22.6 Hours
Core Tip

Core tip: This is a review of the current literature on second-line options in advanced colorectal cancer. This review was performed to analyse the different possible choices in this setting and the best strategies to treat patients with all available active drugs.